News Releases | CCRM

Latest News Releases

March 14, 2023

Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies

January 11, 2023

MicrofluidX and CCRM partner on end-to-end bioprocessing of CAR-T cell therapies

January 9, 2023

CCRM partners with Membio to streamline production of viral vectors for cell and gene therapies

November 29, 2022

Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology

November 7, 2022

Resolution Therapeutics and CCRM sign collaboration agreement to develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies

October 6, 2022

OmniaBio, CCRM Celebrate Commencement of Construction of New Biomanufacturing Facility

June 30, 2022

CDL’s new global Advanced Therapies stream brings together industry leader CCRM, four top universities on two continents

May 31, 2022

OmniaBio Inc. announces private investor

April 18, 2022

CELL AG TECH Signs Agreement To Work With CCRM

March 31, 2022

Funding from Ontario government launches OmniaBio Inc.

March 31, 2022

Invest Ontario Supports New Biomanufacturing Facility in Hamilton

January 24, 2022

CCRM Australia and CATTI collaborate on training initiative

January 5, 2022

CCRM’s Peter Zandstra appointed Member of the Order of Canada

All News Releases

January 18, 2018

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

September 29, 2017

Partnership to Develop Personalized Therapeutics for B-cell Lymphoma and Leukemia

July 13, 2017

Toronto Event Promotes Leadership, Innovation & Entrepreneurship in Regenerative Medicine

April 6, 2017

Regenerative Medicine Alliance of Canada Welcomes the Appointment of Dr. Rod McInnes as Acting President of CIHR

March 24, 2017

Stem Cell & Regenerative Medicine Leaders Join Forces to Advance Canada’s Position in the Field

March 24, 2017

BrainStorm Seeking Approval to Distribute NurOwn in Canada: Signs agreement with CCRM for regulatory support of ALS treatment

December 16, 2016

UniQuest and CCRM sign international deal to develop treatment for chemotherapy-induced neutropenia

December 16, 2016

Ontario Premier Announces C$120M in New Agreements on Mission to South Korea

December 16, 2016

Day One of Premier’s Mission Delivers More Than $120 Million in Agreements

December 16, 2016

Victorians to benefit from new regenerative medicine

2015 and older News Releases

MaRS Centre, West Tower
661 University Avenue, Suite 1002
Toronto, Ontario M5G 1M1 Canada
t: 416-978-3751
f: 416-978-1368

We wish to acknowledge this land on which CCRM operates. For thousands of years, it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land.

Font Resize

Enable Contrast

Accessibility by WAH